Interestingly, Giotopoulos et al. identified potentially targetable pathways in CML such as ERG, MEK, RAF, JAK1/2, and confirmed that MYC is crucial for CML-progression to BC [50]. Here, ERG is linked to chronic myelogenous leukemia, BCR-ABL1 positive.